Höper, M., & Grünig, E. (2017). RESPITE: Switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors. The European respiratory journal, 50(3), . https://doi.org/10.1183/13993003.02425-2016
Chicago-Zitierstil (17. Ausg.)Höper, Marius, und Ekkehard Grünig. "RESPITE: Switching to Riociguat in Pulmonary Arterial Hypertension Patients with Inadequate Response to Phosphodiesterase-5 Inhibitors." The European Respiratory Journal 50, no. 3 (2017). https://doi.org/10.1183/13993003.02425-2016.
MLA-Zitierstil (9. Ausg.)Höper, Marius, und Ekkehard Grünig. "RESPITE: Switching to Riociguat in Pulmonary Arterial Hypertension Patients with Inadequate Response to Phosphodiesterase-5 Inhibitors." The European Respiratory Journal, vol. 50, no. 3, 2017, https://doi.org/10.1183/13993003.02425-2016.